• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Charles & Colvard Ltd filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    5/15/24 9:00:18 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email
    false --06-30 0001015155 0001015155 2024-05-09 2024-05-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): May 9, 2024

     

    Charles & Colvard, Ltd.

    (Exact name of registrant as specified in its charter)

     

    North Carolina 000-23329 56-1928817

    (State or other jurisdiction of

    incorporation)

    (Commission File

    Number)

    (I.R.S. Employer

    Identification No.)

     

    170 Southport Drive  
    Morrisville, North Carolina 27560
    (Address of principal executive offices) (Zip Code)

     

    (919) 468-0399

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s)

    Name of each exchange on

    which registered

    Common Stock, no par value per share CTHR The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b - 2 of the Securities Exchange Act of 1934 (17 CFR 240.12b - 2).

     

    Emerging growth company     ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

     

     

     

     

     

     

    Item 3.03Material Modification to Rights of Security Holders.

     

    To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.

     

    Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    On May 7, 2024, the shareholders of Charles & Colvard, Ltd. (the “Company”) approved a proposal at a special meeting of stockholders (the “Special Meeting”) to amend the Company’s Restated Articles of Incorporation (as amended, the “Articles of Incorporation”) to effect a reverse stock split of the Company’s issued shares of common stock, no par value per share (the “Reverse Stock Split”), at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Company’s Board of Directors (the “Board”) in its sole discretion. On May 9, 2024, the Board approved a reverse stock split ratio of one-for-ten (1:10). On May 14, 2024, the Company filed the Articles of Amendment to the Articles of Incorporation (the “Amendment”) with the North Carolina Secretary of State, with an effective time of 12:01 a.m., Eastern Time on May 17, 2024 (the “Effective Date”).

     

    Impact on Common Stock. After the Effective Date, each shareholder will own a reduced number of shares of common stock. However, the Reverse Stock Split will affect all of the Company’s shareholders uniformly and will not affect any shareholder’s percentage ownership interest in the Company (except to the extent of the rounding up of fractional shares, in which case the Company does not expect any such increase to be material). Voting rights and other rights and preferences of the holders of the Company’s common stock will not be affected by the Reverse Stock Split. The number of shareholders of record will not be affected by the Reverse Stock Split.

     

    The combination of, and reduction in, the number of the Company’s outstanding shares of common stock as a result of the Reverse Stock Split will occur automatically at the Effective Date without any additional action on the part of the Company’s shareholders.

     

    Upon the Reverse Stock Split, the Company intends to treat shareholders holding shares of the Company’s common stock in “street name” (that is, through a broker, bank, or other nominee) in the same manner as registered shareholders whose shares of the Company’s common stock are registered in their names. Brokers, banks, or other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding shares of the Company’s common stock in “street name”; however, these brokers, banks or other nominees may apply their own specific procedures for processing the Reverse Stock Split. The Company encourages shareholders holding shares of the Company’s common stock with a broker, bank, or other nominee, to contact such broker, bank or nominee with any questions in this regard.

     

    Shareholders who hold registered shares of the Company’s common stock in a book-entry form need not take any action to receive their post-Reverse Stock Split shares of the Company’s common stock in registered book-entry form. Shareholders who are entitled to post-Reverse Stock Split shares of the Company’s common stock will automatically be sent a transaction statement to their address of record as soon as practicable after the Effective Date indicating the number of shares of the Company’s common stock such shareholder holds.

     

     

     

     

    Shareholders who hold any shares of the Company’s common stock in certificate form will receive a transmittal letter from the Company’s exchange agent as soon as practicable after the Effective Date. The transmittal letter will be accompanied by instructions specifying how the shareholder can exchange their certificate representing the pre-Reverse Stock Split shares of the Company’s common stock for either: (1) a certificate representing the post-Reverse Stock Split shares of the Company’s common stock or (2) post-Reverse Stock Split shares of the Company’s common stock in a book-entry form, evidenced by a transaction statement that will be sent to such shareholder’s address of record as soon as practicable after the Effective Date indicating the number of shares of the Company’s common stock such shareholder holds. Beginning on the Effective Date of the Reverse Stock Split, each certificate representing pre-Reverse Stock Split shares of the Company’s common stock will be deemed for all corporate purposes to evidence ownership of post-Reverse Stock Split shares.

     

    The new CUSIP number for the Company’s common stock following the Reverse Stock Split is 159765205. The Company’s common stock will open for trading under the new CUSIP number on the Nasdaq Capital Market on May 17, 2024 on a split-adjusted basis under the current ticker symbol “CTHR.”

     

    Impact on Equity Incentives. As of the date of this Current Report on Form 8-K, the Company had 508,834 shares of common stock covered by awards outstanding under the Company’s 2008 Stock Incentive Plan, a copy of which is filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (as amended from time to time, the “2008 Plan”) and 2,350,943 shares of common stock covered by awards and available for future awards under the Company’s 2018 Equity Incentive Plan, a copy of which is filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (as amended from time to time, the “2018 Plan”) (collectively, the “Plans”). Pursuant to the terms of the Plans, as the case may be, as a result of the Reverse Stock Split, as of the Effective Date: each then-outstanding full-value equity award, including each restricted stock award, will be automatically converted into an award covering a number of shares of common stock equal to 1/10 of the number of shares of common stock covered thereby immediately prior to the Reverse Stock Split, rounded down to the nearest whole share; each then-outstanding appreciation equity award, including each stock option award, will be converted into an award covering a number of shares of common stock equal to 1/10 of the number of shares of common stock covered thereby immediately prior to the Reverse Stock Split, rounded down to the nearest whole share, with a per share exercise price equal to the per share exercise price thereof immediately prior to the Reverse Stock Split multiplied by ten, rounded up to the nearest whole penny; the number of shares of common stock available for future grant under the 2018 Plan, and each per-participant limit thereunder, will be reduced to 1/10 of the number of shares applicable thereto immediately prior to the Reverse Stock Split, rounded down to the nearest whole share; and all issued, outstanding and treasury common stock, stock options and per share amounts in the Company’s financial statements and the notes thereto will be retroactively adjusted for all periods to give effect to the Reverse Stock Split. All share and per share amounts in the Company’s financial statements and the notes thereto will be retroactively adjusted for all periods to give effect to the Reverse Stock Split.

     

    The description of the Amendment set forth above does not purport to be complete and is qualified in its entirety by the full text of the Amendment, a copy of which is attached hereto as Exhibit 3.1(a) and is incorporated herein by reference.

     

    Item 7.01Regulation FD Disclosure.

     

    On May 15, 2024, the Company issued a press release announcing the one-for-ten (1:10) Reverse Stock Split. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

     

     

     

     

    In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, which is incorporated into this Item 7.01, is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing.

      

    Item 9.01Financial Statements and Exhibits.

     

    (d)       Exhibits.

     

    Exhibit No.   Description of Document
    3.1    Articles of Amendment to Restated Articles of Incorporation of Charles & Colvard, Ltd.
    99.1   Press Release dated May 15, 2024
    104   Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Charles & Colvard, Ltd.
         
    May 15, 2024 By: /s/ Clint J. Pete
        Clint J. Pete
       

    Chief Financial Officer

     

     

     

    Get the next $CTHR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    SEC Filings

    View All

    Charles & Colvard Ltd filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    10/16/25 4:30:36 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form NT 10-K filed by Charles & Colvard Ltd

    NT 10-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/30/25 5:20:02 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form D filed by Charles & Colvard Ltd

    D - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/12/25 4:40:28 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Charles & Colvard with a new price target

    Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

    9/3/21 8:46:46 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

    RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond ("LGD") offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital ("Ethara"), whose affiliates pioneered Chemical Vapor Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today. In June, Ethara Capital announced a Con

    10/9/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Announces Delisting from Nasdaq

    RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

    4/22/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

    RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For

    3/3/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 9:15:15 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Ethara Capital Llc claimed ownership of 1,353,180 shares (SEC Form 3)

    3 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    10/9/25 3:30:05 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    View All

    Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

    ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

    11/14/24 4:00:00 PM ET
    $CTHR
    $MLSS
    Consumer Specialties
    Consumer Discretionary
    Industrial Specialties
    Health Care

    Charles & Colvard Joins Russell Microcap® Index

    RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

    6/28/21 9:16:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    View All

    CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

    5/2/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

    RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

    4/23/24 4:08:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

    2/13/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/26/24 7:00:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

    SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/14/24 9:00:30 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    11/20/23 4:15:12 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary